A detailed history of Lazard Asset Management LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 20,054 shares of TWST stock, worth $970,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,054
Previous 4,797 318.05%
Holding current value
$970,613
Previous $236,000 283.9%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.72 - $58.88 $560,237 - $898,332
15,257 Added 318.05%
20,054 $906,000
Q2 2024

Aug 14, 2024

BUY
$27.95 - $53.0 $134,076 - $254,241
4,797 New
4,797 $236,000
Q4 2022

Feb 14, 2023

SELL
$21.92 - $39.37 $66,790 - $119,960
-3,047 Reduced 67.04%
1,498 $35,000
Q3 2022

Nov 14, 2022

BUY
$33.44 - $56.56 $62,766 - $106,163
1,877 Added 70.35%
4,545 $160,000
Q2 2022

Aug 09, 2022

BUY
$26.2 - $54.0 $28,060 - $57,834
1,071 Added 67.06%
2,668 $93,000
Q1 2022

May 13, 2022

BUY
$38.58 - $83.27 $26,080 - $56,290
676 Added 73.4%
1,597 $78,000
Q4 2021

Feb 09, 2022

BUY
$75.47 - $135.88 $5,282 - $9,511
70 Added 8.23%
921 $71,000
Q3 2021

Nov 15, 2021

SELL
$95.64 - $131.48 $4,686 - $6,442
-49 Reduced 5.44%
851 $91,000
Q2 2021

Aug 12, 2021

BUY
$88.13 - $142.06 $79,317 - $127,854
900 New
900 $119,000
Q1 2021

May 14, 2021

SELL
$105.48 - $207.97 $143,241 - $282,423
-1,358 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$76.64 - $167.89 $49,432 - $108,289
-645 Reduced 32.2%
1,358 $191,000
Q3 2020

Nov 13, 2020

SELL
$45.46 - $78.79 $28,776 - $49,874
-633 Reduced 24.01%
2,003 $152,000
Q2 2020

Aug 13, 2020

SELL
$26.4 - $45.3 $52,615 - $90,282
-1,993 Reduced 43.05%
2,636 $119,000
Q1 2020

May 14, 2020

BUY
$19.71 - $35.15 $70,088 - $124,993
3,556 Added 331.41%
4,629 $141,000
Q4 2019

Feb 13, 2020

BUY
$21.0 - $26.48 $22,533 - $28,413
1,073 New
1,073 $22,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.73B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.